Laurent Guy

8.3k total citations · 1 hit paper
153 papers, 4.5k citations indexed

About

Laurent Guy is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Laurent Guy has authored 153 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Surgery, 52 papers in Pulmonary and Respiratory Medicine and 36 papers in Molecular Biology. Recurrent topics in Laurent Guy's work include Bladder and Urothelial Cancer Treatments (28 papers), Urinary and Genital Oncology Studies (23 papers) and Urological Disorders and Treatments (21 papers). Laurent Guy is often cited by papers focused on Bladder and Urothelial Cancer Treatments (28 papers), Urinary and Genital Oncology Studies (23 papers) and Urological Disorders and Treatments (21 papers). Laurent Guy collaborates with scholars based in France, United States and United Kingdom. Laurent Guy's co-authors include Robin J. McAnulty, Leonard C. Erickson, Kurt W. Kohn, Nancy A. Sharkey, Dominique Bernard-Gallon, Yves‐Jean Bignon, Jean‐Paul Boiteux, Rachel C. Chambers, Andrew Gray and Jill E. Bishop and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Laurent Guy

148 papers receiving 4.4k citations

Hit Papers

DNA cross-linking and monoadduct repair in nitrosourea-tr... 1980 2026 1995 2010 1980 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurent Guy France 42 1.5k 1.3k 1.3k 820 645 153 4.5k
Haruhito Azuma Japan 41 1.8k 1.2× 993 0.8× 2.0k 1.6× 669 0.8× 259 0.4× 259 5.7k
Scott B. Shappell United States 38 2.6k 1.7× 1.7k 1.4× 1.0k 0.8× 1.2k 1.5× 412 0.6× 75 6.4k
Hiroshi Kanetake Japan 34 2.0k 1.3× 1.1k 0.8× 959 0.8× 899 1.1× 206 0.3× 210 4.1k
Takeo Kosaka Japan 39 1.7k 1.1× 1.6k 1.2× 1.5k 1.2× 1.2k 1.5× 278 0.4× 290 4.8k
Mikio Igawa Japan 40 2.2k 1.4× 1.1k 0.9× 1.1k 0.9× 691 0.8× 288 0.4× 175 4.1k
Chunsun Dai China 52 4.1k 2.7× 962 0.7× 1.2k 1.0× 557 0.7× 744 1.2× 119 8.0k
Sheldon Bastacky United States 35 967 0.6× 868 0.7× 839 0.7× 303 0.4× 356 0.6× 123 3.7k
Toshiyuki Kamoto Japan 37 1.4k 0.9× 1.6k 1.2× 788 0.6× 840 1.0× 156 0.2× 262 3.9k
Friedemann Honecker Germany 39 2.2k 1.4× 729 0.6× 1.8k 1.5× 612 0.7× 350 0.5× 119 4.2k
Akira Yokomizo Japan 40 2.7k 1.8× 1.9k 1.4× 1.1k 0.9× 1.6k 1.9× 257 0.4× 192 5.3k

Countries citing papers authored by Laurent Guy

Since Specialization
Citations

This map shows the geographic impact of Laurent Guy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Guy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Guy more than expected).

Fields of papers citing papers by Laurent Guy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Guy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Guy. The network helps show where Laurent Guy may publish in the future.

Co-authorship network of co-authors of Laurent Guy

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Guy. A scholar is included among the top collaborators of Laurent Guy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Guy. Laurent Guy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bourgne, Céline, et al.. (2025). DNA Methylation in Prostate Cancer: Clinical Implications and Potential Applications. Cancer Medicine. 14(1). e70528–e70528. 3 indexed citations
3.
Tréfond, Ludovic, Laurent Guy, Claude Darcha, et al.. (2023). Efficacy of Mepolizumab for the Treatment of Eosinophilic Cystitis: A Report of 2 Cases. Journal of Investigational Allergology and Clinical Immunology. 34(3). 202–204.
4.
Charbonnel, Cyril, et al.. (2022). Comparaison des biopsies de prostate systématiques, ciblées et combinées pour le diagnostic de cancer de prostate en cas de lésion à l’IRM. Progrès en Urologie. 32(12). 836–842. 1 indexed citations
5.
Roumiguié, M., Xavier Paolettí, Y. Neuzillet, et al.. (2021). Apalutamide, Darolutamide and Enzalutamide in Nonmetastatic Castration-Resistant Prostate Cancer: A Meta-Analysis. Future Oncology. 17(14). 1811–1823. 11 indexed citations
7.
Calvet, Lilian, A. Ravel, Pauline Chauvet, et al.. (2019). Preliminary Trial of Augmented Reality Performed on a Regular and a Robot-Assisted Laparoscopic Partial Nephrectomies. Videourology. 33(3). 3 indexed citations
8.
Mahammedi, Hakim, E. Planchat, Xavier Durando, et al.. (2016). The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study. Oncology. 90(2). 69–78. 112 indexed citations
9.
Boyer, Laurent, et al.. (2013). L’IRM 3 Tesla multi-paramétrique dans le staging du cancer prostatique en pratique courante. Progrès en Urologie. 24(3). 145–153. 6 indexed citations
10.
Gamé, X., Jean‐Nicolas Cornu, G. Robert, et al.. (2013). Les médicaments de l’urètre. Progrès en Urologie. 23(15). 1287–1298. 3 indexed citations
11.
Bastide, C., F. Bruyère, G. Karsenty, Laurent Guy, & François Rozet. (2013). Le traitement hormonal du cancer de la prostate. Progrès en Urologie. 23(15). 1246–1257. 4 indexed citations
12.
Masson-Lecomte, A., Laurent Guy, F. Bruyère, et al.. (2012). A switch from GnRH agonist to GnRH antagonist in castration-resistant prostate cancer patients leads to a low response rate on PSA. World Journal of Urology. 31(2). 339–343. 10 indexed citations
13.
Colin, Pierre, A. Ouzzane, David Yates, et al.. (2012). Influence of Positive Surgical Margin Status After Radical Nephroureterectomy on Upper Urinary Tract Urothelial Carcinoma Survival. Annals of Surgical Oncology. 19(11). 3613–3620. 57 indexed citations
14.
Rouprêt, Morgan, Hervé Wallerand, Olivier Traxer, et al.. (2010). Bilan et prise en charge d’une tumeur de la voie excrétrice urinaire supérieure en 2010 : mise au point du comité de cancérologie de l’Association francaise d’urologie. Progrès en Urologie. 20(4). 260–271. 19 indexed citations
15.
Capietto, Aude-Hélène, Emilie Gross, Nicolas Dauguet, et al.. (2010). Emerging Concepts for the Treatment of Hematological Malignancies with Therapeutic Monoclonal Antibodies. Current Drug Targets. 11(7). 790–800. 9 indexed citations
16.
Adès, Lionel, Simone Boehrer, Thomas Prébet, et al.. (2008). Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study. Blood. 113(17). 3947–3952. 107 indexed citations
17.
Fontana, Luc, Rémy Bosviel, Laëtitia Delort, et al.. (2008). DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort.. PubMed. 28(3B). 1853–6. 46 indexed citations
18.
Léger, Julie, Laurent Guy, F. Desbiez, et al.. (2007). Adrenocortical carcinosarcoma: first european case report. 14. 1 indexed citations
19.
Southcott, AM, Karen L. Jones, S Majumdar, et al.. (1995). Interleukin-8. Differential Expression in Lone Fibrosing Alveolitis and Systemic Sclerosis. American Journal of Respiratory and Critical Care Medicine. 151(5). 1604–1612. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026